Literature DB >> 24175769

MicroRNA-122 promotes proliferation, invasion and migration of renal cell carcinoma cells through the PI3K/Akt signaling pathway.

Ji-Hu Lian1, Wei-Hua Wang, Jia-Qiang Wang, Yu-Hong Zhang, Yi Li.   

Abstract

OBJECTIVE: MicroRNAs (miRNAs) are a small class of non-coding, single-stranded RNAs with a critical role in genesis and maintenance of renal cancer mainly through binding to 3'-untranslated regions (3'UTR) of target mRNAs, which causes a block of translation and/or mRNA degradation. The aim of the present study was to investigate the potential effects of miR-122 in human renal cell carcinomas.
METHODS: The expression level of miR-122 was quantified by qRT-PCR. MTT, colony formation, invasion and migration assays were used to explore the potential functions of miR-122 in human renal cell carcinoma cells.
RESULTS: Cellular growth, invasion and migration in two A498 and 786-O cells were significantly increased after miR-122 transfection. Further experiments demonstrated that overexpression of miR-122 resulted in the increase of phospho-Akt (Ser473) and phospho-mTOR (Ser2448), then activation of mTOR targets, p70S6K and 4E-BP1.
CONCLUSIONS: The up-regulation of miR-122 may play an important role in the progress of renal cancer through activating PI3K/Akt signal pathway and could be a potential molecular target for anti-cancer therapeutics.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24175769     DOI: 10.7314/apjcp.2013.14.9.5017

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  21 in total

1.  miR-122 plays an important role in ochratoxin A-induced hepatocyte apoptosis in vitro and in vivo.

Authors:  Liye Zhu; Tao Yu; Xiaozhe Qi; Bo Yang; Lei Shi; Haoshu Luo; Xiaoyun He; Kunlun Huang; Wentao Xu
Journal:  Toxicol Res (Camb)       Date:  2015-10-08       Impact factor: 3.524

Review 2.  The epigenetic landscape of renal cancer.

Authors:  Mark R Morris; Farida Latif
Journal:  Nat Rev Nephrol       Date:  2016-11-28       Impact factor: 28.314

3.  MiR-122/Wnt/β-catenin regulatory circuitry sustains glioma progression.

Authors:  Guangzhi Wang; Yan Zhao; Yongri Zheng
Journal:  Tumour Biol       Date:  2014-05-27

4.  Paeoniflorin inhibits human gastric carcinoma cell proliferation through up-regulation of microRNA-124 and suppression of PI3K/Akt and STAT3 signaling.

Authors:  Yong-Bin Zheng; Gao-Chun Xiao; Shi-Lun Tong; Yu Ding; Qiu-Shuang Wang; Sheng-Bo Li; Zhi-Nan Hao
Journal:  World J Gastroenterol       Date:  2015-06-21       Impact factor: 5.742

5.  LncRNA XIST serves as a ceRNA to regulate the expression of ASF1A, BRWD1M, and PFKFB2 in kidney transplant acute kidney injury via sponging hsa-miR-212-3p and hsa-miR-122-5p.

Authors:  Qian Cheng; Lin Wang
Journal:  Cell Cycle       Date:  2020-01-08       Impact factor: 4.534

6.  Gld2 activity is regulated by phosphorylation in the N-terminal domain.

Authors:  Christina Z Chung; Nileeka Balasuriya; Emad Manni; Xuguang Liu; Shawn Shun-Cheng Li; Patrick O'Donoghue; Ilka U Heinemann
Journal:  RNA Biol       Date:  2019-05-05       Impact factor: 4.652

Review 7.  The PI3K/AKT Pathway and Renal Cell Carcinoma.

Authors:  Huifang Guo; Peter German; Shanshan Bai; Sean Barnes; Wei Guo; Xiangjie Qi; Hongxiang Lou; Jiyong Liang; Eric Jonasch; Gordon B Mills; Zhiyong Ding
Journal:  J Genet Genomics       Date:  2015-03-19       Impact factor: 4.275

8.  miR-106b-5p targets tumor suppressor gene SETD2 to inactive its function in clear cell renal cell carcinoma.

Authors:  Wei Xiang; Jun He; Chao Huang; Lejun Chen; Dan Tao; Xinchao Wu; Miao Wang; Gang Luo; Xingyuan Xiao; Fuqing Zeng; Guosong Jiang
Journal:  Oncotarget       Date:  2015-02-28

Review 9.  MicroRNAs in renal cell carcinoma: a systematic review of clinical implications (Review).

Authors:  Ming Li; Ying Wang; Yongsheng Song; Renge Bu; Bo Yin; Xiang Fei; Qizhen Guo; Bin Wu
Journal:  Oncol Rep       Date:  2015-02-13       Impact factor: 3.906

10.  Effect of Mir-122 on Human Cholangiocarcinoma Proliferation, Invasion, and Apoptosis Through P53 Expression.

Authors:  Cuiping Wu; Jinmei Zhang; Xiangang Cao; Qian Yang; Dequan Xia
Journal:  Med Sci Monit       Date:  2016-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.